Literature DB >> 11930008

Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.

Kenji Yumoto1, Muneaki Ishijima, Susan R Rittling, Kunikazu Tsuji, Yoko Tsuchiya, Shigeyuki Kon, Akira Nifuji, Toshimitsu Uede, David T Denhardt, Masaki Noda.   

Abstract

Rheumatoid arthritis is one of the most critical diseases that impair the quality of life of patients, but its pathogenesis has not yet been fully understood. Osteopontin (OPN) is an extracellular matrix protein containing Arg-Gly-Asp (RGD) sequence, which interacts with alpha(v)beta3 integrins, promotes cell attachment, and cell migration and is expressed in both synovial cells and chondrocytes in rheumatoid arthritis; however, its functional relationship to arthritis has not been known. Therefore, we investigated the roles of OPN in the pathogenesis of inflammatory process in a rheumatoid arthritis model induced by a mixture of anti-type II collagen mAbs and lipopolysaccharide (mAbs/LPS). mAbs/LPS injection induced OPN expression in synovia as well as cartilage, and this expression was associated with joint swelling, destruction of the surface structures of the joint based on scanning electron microscopy, and loss of toluidine blue-positive proteoglycan content in the articular cartilage in wild-type mice. In contrast, OPN deficiency prevented the mice from such surface destruction, loss of proteoglycan in the articular joint cartilage, and swelling of the joints even when the mice were subjected to mAbs/LPS injection. Furthermore, mAbs/LPS injection in wild-type mice enhanced the levels of CD31-positive vessels in synovia and terminal deoxynucleotidyltransferase-mediated UTP end labeling-positive chondrocytes in the articular cartilage, whereas such angiogenesis as well as chondrocyte apoptosis was suppressed significantly in OPN-deficient mice. These results indicated that OPN plays a critical role in the destruction of joint cartilage in the rheumatoid arthritis model in mice via promotion of angiogenesis and induction of chondrocyte apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11930008      PMCID: PMC123686          DOI: 10.1073/pnas.052523599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Physiology of cytokine pathways in rheumatoid arthritis.

Authors:  W P Arend
Journal:  Arthritis Rheum       Date:  2001-02

Review 2.  TNF-alpha inhibition: the need for a tumor necrosis factor thermostat.

Authors:  J R O'Dell
Journal:  Mayo Clin Proc       Date:  2001-06       Impact factor: 7.616

Review 3.  Rheumatoid arthritis.

Authors:  S Gay
Journal:  Curr Opin Rheumatol       Date:  2001-05       Impact factor: 5.006

Review 4.  Uncoupling of inflammatory and destructive mechanisms in arthritis.

Authors:  W B van den Berg
Journal:  Semin Arthritis Rheum       Date:  2001-04       Impact factor: 5.532

5.  Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology.

Authors:  I Carlson; K Tognazzi; E J Manseau; H F Dvorak; L F Brown
Journal:  Lab Invest       Date:  1997-07       Impact factor: 5.662

6.  Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease.

Authors:  M Schaller; D R Burton; H J Ditzel
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 7.  Rheumatoid arthritis. Treatment of early disease.

Authors:  M Boers
Journal:  Rheum Dis Clin North Am       Date:  2001-05       Impact factor: 2.670

Review 8.  Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 2: the newer drugs and drug strategies.

Authors:  J P Case
Journal:  Am J Ther       Date:  2001 May-Jun       Impact factor: 2.688

9.  Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen.

Authors:  K Terato; D S Harper; M M Griffiths; D L Hasty; X J Ye; M A Cremer; J M Seyer
Journal:  Autoimmunity       Date:  1995       Impact factor: 2.815

Review 10.  Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis.

Authors:  Q Rehman; N E Lane
Journal:  Arthritis Res       Date:  2001-05-18
View more
  58 in total

Review 1.  Intracellular osteopontin (iOPN) and immunity.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

2.  A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis.

Authors:  R Marciano; F Giacopelli; M T Divizia; M Gattorno; E Felici; A Pistorio; A Martini; R Ravazzolo; P Picco
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

3.  No mixing of granulocytes and other lymphocytes in the inflamed joints of parabiosis mice with collagen-induced arthritis: possible in situ generation.

Authors:  Tetsuro Nishizawa; Toshihiko Kawamura; Nakao Izumi; Hiroki Kawamura; Katsuyuki Fujii; Toru Abo
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

Review 4.  Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.

Authors:  T L Rothstein; B Guo
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

Review 5.  Osteopontin: At the cross-roads of myocyte survival and myocardial function.

Authors:  Mahipal Singh; Suman Dalal; Krishna Singh
Journal:  Life Sci       Date:  2014-09-28       Impact factor: 5.037

6.  B cell receptor crosstalk: B cells express osteopontin through the combined action of the alternate and classical BCR signaling pathways.

Authors:  Benchang Guo; Joseph R Tumang; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2008-10-25       Impact factor: 4.407

Review 7.  Association of osteopontin with osteoarthritis.

Authors:  Chao Cheng; Shuguang Gao; Guanghua Lei
Journal:  Rheumatol Int       Date:  2014-05-08       Impact factor: 2.631

8.  Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis.

Authors:  Laura Bazzichi; Lorenzo Ghiadoni; Alessandra Rossi; Melania Bernardini; Mario Lanza; Francesca De Feo; Camillo Giacomelli; Ilaria Mencaroni; Katia Raimo; Marco Rossi; Anna Maria Mazzone; Stefano Taddei; Stefano Bombardieri
Journal:  Mol Med       Date:  2009-06-18       Impact factor: 6.354

9.  Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.

Authors:  Nobuchika Yamamoto; Fumihiko Sakai; Shigeyuki Kon; Junko Morimoto; Chiemi Kimura; Harumi Yamazaki; Ikuko Okazaki; Nobuo Seki; Takashi Fujii; Toshimitsu Uede
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 10.  Osteopontin: a bridge between bone and the immune system.

Authors:  Ellen M Gravallese
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.